Literature DB >> 10480347

Hypoxia induces pivotal tumor angiogenesis control factors including p53, vascular endothelial growth factor and the NFkappaB-dependent inducible nitric oxide synthase and cyclooxygenase-2.

V Chiarugi, L Magnelli, A Chiarugi, O Gallo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10480347     DOI： 10.1007/s004320050312

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


× No keyword cloud information.
  10 in total

Review 1.  Vascular growth factors in cerebral ischemia.

Authors:  S D Croll; S J Wiegand
Journal:  Mol Neurobiol       Date:  2001 Apr-Jun       Impact factor: 5.590

2.  Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.

Authors:  Fiona Murray; Margaret R MacLean; Nigel J Pyne
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

Review 3.  Angiogenesis and the unique nature of tumor matrix.

Authors:  Vincenzo Chiarug; Marco Ruggiero; Lucia Magnelli
Journal:  Mol Biotechnol       Date:  2002-05       Impact factor: 2.695

Review 4.  Vascular endothelial growth factor (VEGF) in seizures: a double-edged sword.

Authors:  Susan D Croll; Jeffrey H Goodman; Helen E Scharfman
Journal:  Adv Exp Med Biol       Date:  2004       Impact factor: 2.622

5.  Androgen receptor targets NFkappaB and TSP1 to suppress prostate tumor growth in vivo.

Authors:  Thomas Nelius; Stephanie Filleur; Alexander Yemelyanov; Irina Budunova; E Shroff; Yelena Mirochnik; Arin Aurora; Dorina Veliceasa; Wuhan Xiao; Zhou Wang; Olga V Volpert
Journal:  Int J Cancer       Date:  2007-09-01       Impact factor: 7.396

6.  Identification of chemical compounds that induce HIF-1alpha activity.

Authors:  Menghang Xia; Ruili Huang; Yi Sun; Gregg L Semenza; Shelley Force Aldred; Kristine L Witt; James Inglese; Raymond R Tice; Christopher P Austin
Journal:  Toxicol Sci       Date:  2009-06-05       Impact factor: 4.849

7.  Clinical procedure for colon carcinoma tissue sampling directly affects the cancer marker-capacity of VEGF family members.

Authors:  Sarah Pringels; Nancy Van Damme; Bram De Craene; Piet Pattyn; Wim Ceelen; Marc Peeters; Johan Grooten
Journal:  BMC Cancer       Date:  2012-11-13       Impact factor: 4.430

8.  Non-conventional role of haemoglobin beta in breast malignancy.

Authors:  Marco Ponzetti; Mattia Capulli; Adriano Angelucci; Luca Ventura; Simona Delle Monache; Cinzia Mercurio; Alessia Calgani; Patrizia Sanità; Anna Teti; Nadia Rucci
Journal:  Br J Cancer       Date:  2017-08-03       Impact factor: 7.640

9.  Identification of small molecule compounds that inhibit the HIF-1 signaling pathway.

Authors:  Menghang Xia; Kun Bi; Ruili Huang; Ming-Hsuang Cho; Srilatha Sakamuru; Susanne C Miller; Hua Li; Yi Sun; John Printen; Christopher P Austin; James Inglese
Journal:  Mol Cancer       Date:  2009-12-09       Impact factor: 27.401

10.  The proteosome inhibitor MG132 attenuates retinoic acid receptor trans-activation and enhances trans-repression of nuclear factor kappaB. Potential relevance to chemo-preventive interventions with retinoids.

Authors:  Valentine B Andela; Randy N Rosier
Journal:  Mol Cancer       Date:  2004-03-22       Impact factor: 27.401
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.